HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Givenchy

This article was originally published in The Rose Sheet

Executive Summary

Givenchy: Swisscare Double Sequence Eye Contour Firming balm "perfects the eye contour area and gives eyes a youthful fresh glow" with a 30-day, two-phase system, the LVMH division said. Sequence 1 balm is designed to be used during the first 18 days of treatment to help "firm the skin and reinforce the action of the support fibers." The first sequence prepares the skin for the second phase of treatment with two patented ingredients -- Soothing Rebalancing Complex and Firming Anti-wrinkle complex. Sequence 2 balm "revitalizes and boosts resistance of fine skin around eyes" and "continues and increases the firming anti- wrinkle action," with three patented ingredients (Specific Firming Anti-wrinkle Complex, Gentle Stimulating Complex and Tautening Complex), Givenchy claims. Available in March, a set of 30 single dose packets will retail for $75...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel